Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1002678

registered interest
date	06/11/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, if he will publish the advice used to inform his Department on the requirements that (a) the decision to prescribe medicinal cannabis products must be made by a specialist doctor and (b) medicinal cannabis products may only be prescribed when the patient has an unmet special clinical need that cannot be met by other treatments.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	188750
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>The prescription of these products by doctors on the Specialist Register of the General Medical Council (GMC) and only where there is an unmet clinical need follows the principles used by the Interim Expert Panel on cannabis-based products for medicinal use. This approach was agreed by senior clinicians on the Expert Panel, Chaired by Dr Michael McBride, Chief Medical Officer for Northern Ireland. This approach was subsequently supported by the Advisory Council on the Misuse of Drugs (ACMD) in their advice to the Home Secretary on rescheduling cannabis. The ACMD advice has been published and is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/further-advice-on-scheduling-of-cannabis-derived-medicinal-products" target="_blank">https://www.gov.uk/government/publications/further-advice-on-scheduling-of-cannabis-derived-medicinal-products</a></p><p>Any unlicensed medicines, including cannabis-based products for medicinal use, will be supplied under long-standing arrangements for the supply of what are known, in healthcare settings, as ‘specials’. This process is underpinned by the Human Medicines Act and, outside of clinical trials, only allows these unlicensed medicines to be prescribed where there is an unmet clinical need. This restriction is in place because unlicensed medicines have not been through the same quality, safety and efficacy tests as licenced medicines.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 12/11/2018 17:05:51 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	1439 label Biography information for Norman Lamb

988887

registered interest
date	16/10/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, whether GPs will be required to notify (a) the police and (b) the Home Office when making prescriptions for medicinal cannabis.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	180264
answer	answer is ministerial correction date of answer 24/10/2018 answer text <p>From 1 November, certain cannabis-based products for medicinal use, that meet conditions related to the quality of their manufacture and supply routes, can be prescribed by doctors on the specialist register of the General Medical Council (GMC). GPs will not be able to prescribe cannabis-based medicinal products for their patients.</p><p>There is no requirement for specialist doctors to notify the police or the Home Office when issuing prescription for these products. Controlled Drug Accountable Officers have a statutory responsibility to secure the safe management and use of controlled drugs. This includes a duty to monitor the prescribing, supply and administration (if applicable) of all controlled drugs and liaise with the police to investigate suspected diversion.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 24/10/2018 15:40:57 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4491 label Biography information for Vicky Foxcroft

971604

registered interest
date	11/09/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what assessment he has made of whether there is a correlation between the unrestricted sale of natural cannabis oil in health stores and the number of thefts on the high street; and if he will make a statement.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	173514
answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>We do not hold data to assess whether there is a correlation between the sale of natural cannabis oil and the number of thefts on the high street.</p><p>A CBD, or cannabidiol product, in its pure form is not controlled under the Misuse of Drugs Act 1971. However, a CBD product, which contains any trace of the psychoactive compounds that are found in cannabis, such as THC, is considered to be a controlled substance under the Misuse of Drugs Act 1971 and therefore unlawful to possess and supply unless it fits the criteria for an ‘exempt product’ under the Misuse of Drugs Regulations 2001.</p><p>Enforcement of illegal sales of drugs is an operational matter for the police but we expect them to enforce the law.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 09/10/2018 15:30:25 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	308 label Biography information for Mr Jim Cunningham

968170

registered interest
date	05/09/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, how many licence applications for medicinal cannabis have been received by the expert panel; and what the status is of those applications.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	170718
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>Government has announced an aim to reschedule cannabis in the autumn. This will enable specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need. In the interim the Expert Panel has been established to review applications from specialist clinicians who wish to prescribe specified cannabis derived medicinal products. For each application, the panel are looking for a specialist clinician to meet their criteria and show that there are exceptional clinical circumstances before recommending that a licence should be issued.</p><p>As of 06 September 2018 there have been forty four inquiries to the expert panel mailbox from members of the public, patients, doctors and press. The number of applications to the panel has been small there is a significant risk that even aggregate information disclosed about applications could be linked to personal details (made available through media reporting). Given that the Home Office has a duty to protect these individuals the actual number of applications cannot be disclosed.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd grouped question UIN 170719 question first answered 10/09/2018 16:02:09 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	1439 label Biography information for Norman Lamb

968171

registered interest
date	05/09/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, how many inquiries the medicinal cannabis licensing panel has received from potential applicants.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	170719
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>Government has announced an aim to reschedule cannabis in the autumn. This will enable specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need. In the interim the Expert Panel has been established to review applications from specialist clinicians who wish to prescribe specified cannabis derived medicinal products. For each application, the panel are looking for a specialist clinician to meet their criteria and show that there are exceptional clinical circumstances before recommending that a licence should be issued.</p><p>As of 06 September 2018 there have been forty four inquiries to the expert panel mailbox from members of the public, patients, doctors and press. The number of applications to the panel has been small there is a significant risk that even aggregate information disclosed about applications could be linked to personal details (made available through media reporting). Given that the Home Office has a duty to protect these individuals the actual number of applications cannot be disclosed.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd grouped question UIN 170718 question first answered 10/09/2018 16:02:09 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	1439 label Biography information for Norman Lamb

946807

registered interest
date	23/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, with reference to the recommendation of the Advisory Council on the Misuse of Drugs that medicinal cannabis products be moved out of Schedule 1 and into Schedule 2 of the Misuse of Drugs Regulations, how long it will take to reclassify the medicinal cannabis oil used by Alfie Dingley and Billy Caldwell; and whether he plans to ensure that all patients who might benefit from such treatment will be able to access medicinal cannabis by the time the House returns from its summer recess.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	167359
answer	answer is ministerial correction date of answer 07/09/2018 answer text <p>Following the short term ACMD advice, the Home Secretary has confirmed that cannabis-derived medicinal products will be rescheduled. This means that senior clinicians will be able to prescribe the medicines to patients with an exceptional clinical need.</p><p>The Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency will now develop a clear definition of what constitutes a cannabis-derived medicinal product. Only products meeting this definition will be rescheduled. Other forms of cannabis will be kept under strict controls and will not be available on prescription. We will provide more details about this definition and the kinds of products that will be covered in due course.</p><p>The Home Secretary has been clear that speed is of the essence and the products will be available on prescription in the autumn.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 07/09/2018 18:35:25 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi

942648

registered interest
date	16/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what guidance his Department has given to the respective health departments in the devolved nations on access to medical cannabis under licence.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	164519
answer	answer is ministerial correction date of answer 20/07/2018 answer text <p>Advice about clinical applications for medicinal cannabis is available on the gov.uk website, which was publicised at the time of the Expert Panel’s launch. This makes clear that applications must be made by senior clinicians who are on the General Medical Council’s relevant specialist register with an active license to practise.</p><p>The Department for Health and Social Care is working with NHS England and equivalents in the devolved nations to ensure that cannabis based medicinal products are sourced and supplied where a licence is granted. In the longer term, prescribing guidance will be developed following any decision to reschedule these products.</p><p> </p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 20/07/2018 13:59:35 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi

942651

registered interest
date	16/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what discussions he is having with NHS England to ensure that consultants are aware of the licencing process for access to medical cannabis.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	164520
answer	answer is ministerial correction date of answer 20/07/2018 answer text <p>Advice about clinical applications for medicinal cannabis is available on the gov.uk website, which was publicised at the time of the Expert Panel’s launch. This makes clear that applications must be made by senior clinicians who are on the General Medical Council’s relevant specialist register with an active license to practise.</p><p>The Department for Health and Social Care is working with NHS England and equivalents in the devolved nations to ensure that cannabis based medicinal products are sourced and supplied where a licence is granted. In the longer term, prescribing guidance will be developed following any decision to reschedule these products.</p><p> </p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 20/07/2018 14:01:07 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi

939883

registered interest
date	12/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, for what reasons his Department charges the rate that it does for processing licence applications for medical cannabis.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	163489
answer	answer is ministerial correction date of answer 30/08/2018 answer text <p>Fees for all drug licences issued are charged on a full cost recovery basis, reflecting the total cost of processing that case from start to finish. Where a fee is payable, it is charged in accordance with the Misuse of Drugs (Fees) Regulations 2010 and payable by the ‘applying’ organisation (e.g. an NHS trust). Fee payments are not ordinarily met by individual patients.</p><p>The Government is committed to reviewing the fees paid for licenses that are awarded as a result of the advice of the Expert Panel. That review will take place urgently and will conclude before summer recess, with any legislation laid before the House at the first available date following its conclusion.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 30/08/2018 13:52:05 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	151 label Biography information for Tom Brake

935292

registered interest
date	06/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, if he will discuss with the Department of Health in Northern Ireland the conditions of the licence for Billy Caldwell to ensure he can receive medicinal cannabis without having to travel to Belfast.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	161589
answer	answer is ministerial correction date of answer 11/07/2018 answer text <p>This is a devolved matter for the Department of Health in Northern Ireland with whom we work collaboratively. Licence conditions can be individually tailored to fit an individual situation based on assessment of risk and in the interests of safeguarding those who are licensed or indirectly benefit from a licence.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 11/07/2018 15:58:27 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi